Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • From the Analyst's Couch
  • Published:

UK academic drug discovery


This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Drug discovery research in UK academic groups compared with US academic groups and the pharmaceutical industry.
Figure 2: Funding sources for academic drug discovery.


  1. Frye, S. et al. US academic drug discovery. Nature Rev. Drug Discov. 10, 409–410 (2011).

    CAS  Google Scholar 

  2. Rathi, A. Removing boundaries. RSC News 10–11 (Jan 2013).

Download references


The authors thank the survey participants and acknowledge the help received from Thomson Reuters Life Sciences to run and analyse the survey, and in supplying comparative industry data.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Cathy Tralau-Stewart.

Ethics declarations

Competing interests

C.T.-S. and C.L. act as consultants to academia, biotechnology companies and pharmaceutical companies.

Supplementary information

Supplementary information S1 (box)

Academic Drug Discovery Study (PDF 742 kb)

Supplementary information S2 (box)

Survey methods and supplementary data (PDF 2798 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tralau-Stewart, C., Low, C. & Marlin, N. UK academic drug discovery. Nat Rev Drug Discov 13, 15–16 (2014).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research